ストックスクリーナーアプリを入手
1.50
0.67%
0.01
前日終値:
$1.49
開ける：
$1.47
24時間の取引高:
76,879
Relative Volume:
0.65
時価総額：
$111.77M
収益：
-
当期純損益:
$-19.57M
株価収益率:
-0.4792
EPS:
-3.13
ネットキャッシュフロー:
$-17.24M
1週間 パフォーマンス:
+2.04%
1か月 パフォーマンス:
-7.41%
6か月 パフォーマンス:
-18.92%
1年 パフォーマンス:
-46.04%
1日の値動き範囲:
$1.39
$1.5145
1週間の範囲:
$1.33
$1.76
52週間の値動き範囲:
$1.33
$4.20
Inhibikase Therapeutics Inc Stock (IKT) Company Profile
名前
Inhibikase Therapeutics Inc
セクター
電話
(302) 295-3800
住所
1000 N. WEST STREET, SUITE 1200, WILMINGTON
IKT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IKT
Inhibikase Therapeutics Inc
|
1.50 | 111.03M | 0 | -19.57M | -17.24M | -3.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inhibikase Therapeutics Inc Stock (IKT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-12 | ダウングレード | H.C. Wainwright | Buy → Neutral |
Inhibikase Therapeutics Inc (IKT) 最新ニュース
Will Inhibikase Therapeutics Inc. stock recover after recent dropProfit Target & Trade Opportunity Analysis - newser.com
Will Inhibikase Therapeutics Inc. stock beat EPS estimatesMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Analyzing Inhibikase Therapeutics Inc. with risk reward ratio chartsTrade Signal Summary & Short-Term High Return Strategies - newser.com
Will Inhibikase Therapeutics Inc. (IQT0) stock top growth indexes2025 Winners & Losers & Long-Term Growth Stock Strategies - newser.com
Can volume confirm reversal in Inhibikase Therapeutics Inc.July 2025 Short Interest & Accurate Buy Signal Alerts - newser.com
How to build a dashboard for Inhibikase Therapeutics Inc. stockTrade Signal Summary & Technical Pattern Based Signals - newser.com
Can Inhibikase Therapeutics Inc. recover in the next quarterQuarterly Portfolio Review & Precise Trade Entry Recommendations - newser.com
Is Inhibikase Therapeutics Inc. stock cheap compared to fundamentalsJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Using data models to predict Inhibikase Therapeutics Inc. stock movementQuarterly Growth Report & Real-Time Market Sentiment Reports - newser.com
Is Inhibikase Therapeutics Inc. (IQT0) stock overpriced at current multiples2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
What makes Inhibikase Therapeutics Inc. stock attractive to growth fundsMarket Performance Summary & Verified Chart Pattern Signals - newser.com
Why Inhibikase Therapeutics Inc. stock is a must watch in 2025July 2025 Momentum & Consistent Profit Alerts - newser.com
Earnings visualization tools for Inhibikase Therapeutics Inc.July 2025 Opening Moves & Technical Buy Zone Confirmations - newser.com
Why Inhibikase Therapeutics Inc. stock appeals to analystsM&A Rumor & AI Enhanced Market Trend Forecasts - newser.com
How Inhibikase Therapeutics Inc. stock reacts to Fed rate cutsJuly 2025 Gainers & Daily Technical Stock Forecast Reports - fcp.pa.gov.br
Tools to monitor Inhibikase Therapeutics Inc. recovery probabilityWeekly Earnings Recap & Low Risk Investment Opportunities - newser.com
Can Inhibikase Therapeutics Inc. stock maintain operating marginsProduct Launch & Accurate Technical Buy Alerts - newser.com
Is Inhibikase Therapeutics Inc. (IQT0) stock a defensive play amid uncertainty2025 Pullback Review & AI Powered Market Trend Analysis - newser.com
Is Inhibikase Therapeutics Inc. reversing from oversold territoryPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
What institutional flow reveals about Inhibikase Therapeutics Inc.Portfolio Update Summary & AI Based Buy and Sell Signals - newser.com
Will Inhibikase Therapeutics Inc. (IQT0) stock profit from AI boomJuly 2025 Highlights & Verified Short-Term Plans - newser.com
Signal strength of Inhibikase Therapeutics Inc. stock in tech scannersJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Understanding Inhibikase Therapeutics Inc.’s price movementJuly 2025 Retail & Weekly Momentum Picks - newser.com
Will Inhibikase Therapeutics Inc. price bounce be sustainableOil Prices & AI Driven Price Forecasts - newser.com
How rising interest rates impact Inhibikase Therapeutics Inc. stockJuly 2025 Sentiment & Daily Profit Maximizing Tips - fcp.pa.gov.br
Can Inhibikase Therapeutics Inc. stock reach $100 price target2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock fits value portfoliosTrade Ideas & Detailed Earnings Play Alerts - newser.com
Top chart patterns to watch in Inhibikase Therapeutics Inc.Weekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock trades below fair value2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Inhibikase Therapeutics Inc (IKT) 財務データ
収益
当期純利益
現金流量
EPS
5.44%
0.70%
大文字化:
|
ボリューム (24 時間):